The Tecnimede Group, with the purpose of developing new drugs that contribute to improving people's health and quality of life, researches and develops new chemical entities that enable the treatment of the most relevant conditions affecting society, with particular emphasis on infectious diseases and nervous system diseases. The varied patented chemical entities available to our scientists and researchers ensure they work every day to find new and improved solutions to meet the population’s needs.